ReviewBioresources and bioprocessing2025
Valorisation of fish scales and bones: a sustainable source of bioactive proteins and collagen for nutraceuticals.
Review in Bioresources and bioprocessing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Partial Replacement of Fish Meal with Fish Scale Meal Enhances Body Color Brightness and Iridophore Development in Koi (Animals : an open access journal from MDPI · 2026Article
- Simulated Gastrointestinal Digestion of Tilapia (Foods (Basel, Switzerland) · 2026Article
- Physicochemical and Functional Properties of Type B Gelatin Obtained from Nile Tilapia (Pharmaceutics · 2026Article
- Processed carp scales as a functional food for sepsis protection: enhancing amino acid content and bioactive peptide profiles.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Fish scales and bones, traditionally regarded as low-value seafood by-products, represent abundant and sustainable sources of collagen and bioactive proteins with high nutraceutical potential. These tissues typically contain 30-40% organic collagen matrix and 60-70% hydroxyapatite minerals, making them rich substrates for recovery. Advances in green and enzymatic extraction methods now achieve collagen yields of up to 25-35%, with ultrasound- and microwave-assisted extraction reducing processing times from days to minutes while preserving the triple-helix structure and bioactivity. Enzymatically derived peptides demonstrate potent health-promoting effects, with antioxidant capacities comparable to or exceeding vitamins C and E, ACE-inhibitory peptides lowering blood pressure in preclinical models, and clinical trials showing that daily supplementation with 10 g fish collagen peptides for 8-12 weeks improves skin hydration, elasticity, wrinkle reduction, and reduces osteoarthritis-related joint pain. These marine biomolecules, when delivered through advanced nanocarrier systems such as nanoliposomes and nanoemulsions, exhibit enhanced bioavailability, stability, and consumer acceptability. Beyond health benefits, valorisation of fish by-products supports environmental sustainability by diverting waste and contributing to the circular bioeconomy. Despite challenges in scalability, regulatory compliance, and standardization, ongoing technological innovations position fish scales and bones as promising raw materials for next-generation nutraceuticals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.